-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$1.00-33.77% Downside
Agile Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Agile Therapeutics, Inc.?
Agile Therapeutics, Inc. has been rated by research analysts at Maxim Group in the past 90 days.